MRI of Perianal Fistulas: Anatomy, Classification, and Treatment Monitoring

A practical radiology review of MRI of Perianal Fistulas: Anatomy, Classification, and Treatment Monitoring, focused on imaging findings, differential diagnosis, reporting points, and high-yield teaching pearls.

• All anal canal fistulas pass through the intersphincteric space at some point
• → Even trans- or suprasphincteric ones. Don’t forget this anatomic constant.
• Female anterior sphincter anatomy = higher anovaginal risk
• → Shorter anterior external sphincter → intersphincteric tracts can reach posterior vagina easier.
• St James vs Parks
• Parks = surgical anatomy-based
• St James = MRI-based + complexity (abscess/branching)
• Grade 5 (St James) = any supralevator extension (highest complexity)
• Supralevator ≠ Suprasphincteric
• Supralevator = extension above levator (modifier)
• Suprasphincteric = specific looping path
• → Not interchangeable.
• Radiologic healing ≠ Clinical remission
• Only ~25% achieve MRI healing despite ~50% clinical remission.
• Persistent T2 hyperintense fluid = higher relapse risk.
• PFCD may occur without luminal disease
• → Isolated perianal Crohn exists. Don’t assume bowel inflammation.
• Chronic fistula → Mucinous adenocarcinoma risk
• T2 hyperintense microcystic tissue
• Minimal diffusion restriction
• Mimics fluid tract → biopsy suspicious chronic changes
• Post-contrast may better show internal opening
• → But T2 still adequate for classification.
• What a Radiology Resident MUST Master & Apply Daily

1. Anatomy-Based Reading Strategy (Non-Negotiable)

Always follow this order

• Internal opening (most important surgical landmark)
• Primary tract course
• External opening
• Secondary tracts
• Abscess
• Supralevator extension
• Proctitis (in PFCD)
• If you don’t localize the internal opening → your report is incomplete.

2. Classification You Should Fluently Use

• Always state Parks classification (ESGAR recommendation)
• Add St James grade if helpful

Practical rule

• Linear = Grade 1 (inter) or 3 (trans)
• Branch/abscess = Grade 2 or 4
• Above levator = Grade 5
• Keep it simple and reproducible.

3. Differentiate Cryptoglandular vs PFCD

• Feature Cryptoglandular PFCD
• Origin Anal gland Anorectal junction / proctitis
• Pattern Predictable Branching, high origin
• Chronicity Often curable Cyclic inflammation
• MRI role Surgical planning Serial monitoring
• PFCD = longitudinal disease → always compare prior MRI.

4. Active vs Fibrotic Tract (Critical in PFCD)

Active tract

• T2 hyperintense
• Rim enhancement
• Possible diffusion restriction

Fibrotic tract

• T2 hypointense
• Minimal/no enhancement
• No diffusion restriction

Clinical implication

• Fluid persistent → relapse risk
• Fibrotic → sustained remission
• Always comment on composition in follow-ups.

5. Recognize Surgical Impact Findings

Surgeons care about

• % of external sphincter involved
• Abscess needing drainage
• Seton position
• Supralevator disease
• Horseshoe abscess
• If you miss supralevator extension → major surgical complication risk.

6. MRI Protocol Awareness (Board-Level + Practical)

• Small FOV high-resolution T2 = workhorse
• Oblique axial plane aligned with anal canal = essential
• Fat suppression → STIR/Dixon more reliable than freq-selective
• DWI + Post-contrast → improve abscess/internal opening detection
• Never interpret off-axis planes blindly.

7. Long-Term PFCD: Red Flags

• Persistent tract despite years of seton
• New branching on serial MRI
• Increasing fibrosis with clinical worsening
• T2 bright microcystic tissue → suspect malignancy

What You Should Change in Your Reporting Tomorrow

• Use structured search pattern

Always mention

• Internal opening clock-face position
• Parks classification
• Abscess presence/size
• Supralevator extension
• Tract composition (active vs fibrotic)
• Comparison with prior MRI

In PFCD

• State if stable / improved / new branching
• Mention proctitis

Ultimate Take-Home Mental Model

• Perianal MRI is NOT just anatomy mapping.

It is

• In cryptoglandular → a surgical roadmap
• In PFCD → a disease activity biomarker over time